Chronic Hepatitis B
Showing 1 - 25 of 400
Chronic Hepatitis B Trial (Imdusiran (AB-729))
Not yet recruiting
- Chronic Hepatitis B
- Imdusiran (AB-729)
- (no location specified)
Nov 30, 2023
Chronic Hepatitis b Trial in Chongqing, Xi'an (Placebo, TQA3605 tablets, Entecavir dispersible tablets)
Recruiting
- Chronic Hepatitis b
- Placebo
- +4 more
-
Chongqing, Chongqing, China
- +2 more
Nov 27, 2023
Gut Microbiome in People Living With HIV and HBV
Not yet recruiting
- Human Immunodeficiency Virus
- +2 more
- (no location specified)
Nov 8, 2023
Chronic Hepatitis B Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (VIR-2218 and
Not yet recruiting
- Chronic Hepatitis B
- VIR-2218 and peginterferon alfa-2a
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Chronic Hepatitis b Trial in Wuhan (TQA3038 injection, TQA3038 injection matching )
Not yet recruiting
- Chronic Hepatitis b
- TQA3038 injection
- TQA3038 injection matching placebo
-
Wuhan, Hubei, ChinaTongji Hospital
Oct 17, 2023
Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)
Recruiting
- Chronic Hepatitis B
- VRON-0200-AdC6
- VRON-0200-AdC7
-
Hong Kong, Hong Kong
- +1 more
Oct 6, 2023
Chronic Hepatitis b Trial in Lyon (procedure, biological, other)
Not yet recruiting
- Chronic Hepatitis b
- Investigation of the intrahepatic compartment using the fine needle aspiration (FNA) technique
- +2 more
-
Lyon, FranceHepatology Department - Hospices Civils de Lyon
Sep 14, 2023
Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)
Not yet recruiting
- Chronic Hepatitis b
- AB-101
- +2 more
-
Auckland, New ZealandNew Zealand Clinical Research Auckland
Jul 26, 2023
Chronic Hepatitis b Trial (RBD1016, RBD1016+PegIFN-a)
Not yet recruiting
- Chronic Hepatitis b
- (no location specified)
Jul 25, 2023
Chronic Hepatitis B, Non-alcoholic Fatty Liver Disease Trial in Taipei (exercise)
Enrolling by invitation
- Chronic Hepatitis B
- Non-alcoholic Fatty Liver Disease
- exercise
-
Taipei, Zhongzheng Dist., TaiwanNational Taiwan University Hospital
Jul 13, 2023
Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)
Not yet recruiting
- Chronic Hepatitis B
- HRS9950 tablets
- HRS9950 placebo tablets
- (no location specified)
Jun 7, 2023
Chronic Hepatitis B Trial in Beijing (TCR-T)
Active, not recruiting
- Chronic Hepatitis B
- TCR-T
-
Beijing, ChinaThe Fifth Medical Center of PLA General Hospital
Jun 13, 2023
Hepatic Fibrosis on Hepatic Steatosis Using Ultrasound
Not yet recruiting
- Hepatic Steatosis
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
May 21, 2023
Chronic Hepatitis b, Tenofovir Alafenamide Fumarate Trial in Hangzhou (Tenofovir Alafenamide Tablets)
Recruiting
- Chronic Hepatitis b
- Tenofovir Alafenamide Fumarate
- Tenofovir Alafenamide Tablets
-
Hangzhou, Zhejiang, ChinaHangzhou First People's Hospital
May 8, 2023
Chronic Hepatitis b Trial in Rotterdam (ISA104, Placebo)
Not yet recruiting
- Chronic Hepatitis b
- ISA104
- Placebo
-
Rotterdam, NetherlandsErasmus MC
Apr 21, 2023
Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)
Active, not recruiting
- Chronic Hepatitis B
- NrtIs
- +2 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 20, 2023
Chronic Hepatitis B Trial in Seoul (Standard of care)
Active, not recruiting
- Chronic Hepatitis B
- Standard of care
-
Seoul, Korea, Republic of
- +3 more
Mar 29, 2023
HBV Infection, Chronic Hepatitis b Trial in China (Tenofovir Amibufenamide(TMF))
Recruiting
- HBV Infection
- Chronic Hepatitis b
- Tenofovir Amibufenamide(TMF)
-
Beijing, China
- +11 more
Mar 22, 2023
Chronic Hepatitis b Trial in Taiwan (Nuc Discontinuation, Entecavir or Tenofovir)
Active, not recruiting
- Chronic Hepatitis b
- Nuc Discontinuation
- Entecavir or Tenofovir
-
Chiayi City, Taiwan
- +5 more
Mar 30, 2023
COVID-19 Infection and Its Clinical Prognosis in Chronic
Recruiting
- Chronic Hepatitis B
- COVID-19 Infection
- Interferon
- nucleoside analogues
-
Beijing, Beijing, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023
Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis
Recruiting
- Chronic Hepatitis b
- Non-Alcoholic Fatty Liver Disease
-
Beijing, Select A State Or Province, ChinaYameng Sun
Mar 27, 2023
Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)
Not yet recruiting
- Chronic Hepatitis b
- +2 more
- Anti-PD-1 antibody
- +2 more
-
Chongqing, Chongqing, ChinaThe 2nd affiliated Hospital of Chongqing Medical University
Mar 14, 2023
Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)
Not yet recruiting
- Chronic Hepatitis B
- GS-2829
- +3 more
- (no location specified)
Mar 14, 2023